<\/p>\n
At the end of 2008, the market for generic drugs in Italy could experience a 25% boom, thanks to the expiry of some patents.<\/font><\/strong> To say it is Nello Martini, director general of the Italian Medicines Agency (Aifa), who participated. \u00abIn 2008\u00bb, recalled Martini, \u00abthere are molecules of extraordinary importance that in Italy lose their patent coverage. by the end of 2008, an increase in the Italian market for generics of 25% is therefore expected\u00bb. the boom in generics, however, will have to "fight" against the reluctance of Italians to use generic drugs instead of "designer" ones. On the research front, however, Italy is making leaps forward: \u00abFrom 2000 to today\u00bb, added the AIFA director, \u00abthere have been over 300 clinical trials in Italy, and I must say that it is increasing phase 2 experimentation in a sensitive manner, and that there are important signs of an increase also for the phase 1 experimentation". Pharmacy News of 24\/06\/2008 N. 6 JUNE 2008 p. 4 <\/p>","protected":false},"excerpt":{"rendered":" Alla fine del 2008 il mercato dei farmaci generici in italia potrebbe avere un boom del 25%, grazie alla scadenza di alcuni brevetti. A dirlo è Nello Martini, direttore generale dell’Agenzia italiana del Farmaco (Aifa), che ha partecipato. «Nel 2008», ha ricordato Martini, «ci sono molecole di straordinaria importanza che in italia perdono la …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12379"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12379\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}